Neuland Laboratories Fair Value
Neuland Laboratories (NEULANDLAB) average fair value is ₹4588.03 across 8 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹16693.0 (-72.52%), fair value range ₹1442.31–₹11278.74. See NEULANDLAB book value to compare market price against book value per share.
Fair Value Analysis Export
NEULANDLAB Fair Value vs Current Price — Valuation Summary
NEULANDLAB average fair value, fair value range, price gap and valuation status across 8 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit NEULANDLAB screener.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Benjamin Graham Number
Discounted Cash Flow (DCF)
NEULANDLAB Fair Value Analysis — Data Sources & Coverage
Neuland Laboratories financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. Examine Neuland Laboratories quarterly financials for recent quarterly revenue, profit and EPS trends.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
NEULANDLAB vs Healthcare Sector Peers — P/E, P/B & Market Cap
Neuland Laboratories P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| Auro Laboratories | AUROLAB | 91.49 | 3.91 | ₹165 |
| Sun Pharmaceutical | SUNPHARMA | 41.43 | 5.83 | ₹442,581 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.